Transplantation, AutologousPeripheral Blood Stem Cell TransplantationAntineoplastic Combined Chemotherapy ProtocolsCombined Modality TherapyCyclophosphamideHematopoietic Stem Cell TransplantationAntineoplastic AgentsTreatment OutcomeChemotherapy, AdjuvantLymphoma, Non-HodgkinSalvage TherapyDose-Response Relationship, DrugKidney TransplantationCisplatinTransplantsDoxorubicinGraft RejectionDrug Administration ScheduleTime FactorsSurvival AnalysisImmunosuppressive AgentsGraft SurvivalTransplantation, HomologousDisease-Free SurvivalSurvival RateNeoadjuvant TherapyPrognosisHeart TransplantationEtoposideBreast NeoplasmsNeoplasm StagingBone Marrow TransplantationFollow-Up StudiesTransplantationTissue DonorsLung NeoplasmsMethotrexateLung TransplantationNeoplasmsCarboplatinPaclitaxelProspective StudiesNeoplasm Recurrence, LocalVinblastineInduction ChemotherapyRecurrenceTaxoidsCyclosporineIfosfamideDrug Resistance, NeoplasmAntimetabolites, AntineoplasticBleomycinAdministration, OralTissue and Organ ProcurementCytarabineDeoxycytidineTacrolimusPostoperative ComplicationsAntineoplastic Agents, AlkylatingImmunosuppressionOrganoplatinum CompoundsRadiotherapy DosageNeutropeniaInfusions, IntravenousKaplan-Meier EstimateRetrospective StudiesRisk FactorsVomitingClinical Trials as TopicLiving DonorsNeoplasm MetastasisHodgkin DiseaseNauseaAnthracyclinesMelphalanWaiting ListsCarcinoma, Non-Small-Cell LungOvarian NeoplasmsChemotherapy, Cancer, Regional PerfusionAdenocarcinomaAntineoplastic Agents, PhytogenicRadiotherapyGranulocyte Colony-Stimulating FactorImmunocompromised HostTesticular NeoplasmsAntibodies, MonoclonalCarmustineAntibiotics, AntineoplasticLiver NeoplasmsRadiotherapy, AdjuvantCytomegalovirus InfectionsLeukopeniaColorectal NeoplasmsMycophenolic AcidHistocompatibility TestingMultivariate AnalysisFetal Tissue TransplantationBrain NeoplasmsFatal OutcomePrecursor Cell Lymphoblastic Leukemia-Lymphoma